Royce & Associates’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.81M | Buy |
|
|||||
|
2025
Q2 | $2.69M | Sell |
|
|||||
|
2025
Q1 | $3.53M | Sell |
|
|||||
|
2024
Q4 | $3.13M | Buy |
|
|||||
|
2024
Q3 | $2.02M | Buy |
|
|||||
|
2024
Q2 | $1.05M | Hold |
|
|||||
|
2024
Q1 | $1.04M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.37M | Sell |
|
|||||
|
2021
Q1 | $1.46M | Hold |
|
|||||
|
2020
Q4 | $2.09M | Hold |
|
|||||
|
2020
Q3 | $1.83M | Hold |
|
|||||
|
2020
Q2 | $2.12M | Sell |
|
|||||
|
2020
Q1 | $2.36M | Sell |
|
|||||
|
2019
Q4 | $6.21M | Sell |
|
|||||
|
2019
Q3 | $2.12M | Sell |
|
|||||
|
2019
Q2 | $2.95M | Sell |
|
|||||
|
2019
Q1 | $2.6M | Sell |
|
|||||
|
2018
Q4 | $937K | Hold |
|
|||||
|
2018
Q3 | $1.15M | Sell |
|
|||||
|
2018
Q2 | $2.84M | Sell |
|
|||||
|
2018
Q1 | $2.34M | Buy |
|
|||||
|
2017
Q4 | $4.93M | Hold |
|
|||||
|
2017
Q3 | $4.89M | Hold |
|
|||||
|
2017
Q2 | $4.85M | Hold |
|
|||||
|
2017
Q1 | $3.44M | Buy |
|